These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
| o |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
Delaware
|
33-1022198
|
|
|
(State or other jurisdiction of
incorporation or organization)
|
(I.R.S. Employer
Identification No.)
|
| Large accelerated filer x | Accelerated filer o | Non-accelerated filer o (Do not check if a smaller reporting company) | Smaller reporting company o |
|
|
Page
|
||||
|
|
|
3
|
|||
|
|
|||||
|
|
|||||
|
|
4
|
||||
|
|
5
|
||||
|
|
6
|
||||
|
|
7
|
||||
|
|
22
|
||||
|
|
33
|
||||
|
|
34
|
||||
|
|
|||||
|
|
34
|
||||
|
|
34
|
||||
|
|
35
|
||||
|
|
35
|
||||
|
|
35
|
||||
|
|
36
|
||||
|
|
37
|
||||
|
|
|||||
|
FINANCIAL INFORMATION
|
|
FINANCIAL STATEMENTS
|
|
Three Months Ended
|
Six Months Ended
|
||||||||||||||
|
June 30,
|
June 30,
|
||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
||||||||||||
|
Net sales
|
$
|
342,212
|
$
|
263,044
|
$
|
668,050
|
$
|
516,933
|
|||||||
|
Cost of sales
|
161,194
|
135,003
|
316,722
|
264,083
|
|||||||||||
|
Gross profit
|
181,018
|
128,041
|
351,328
|
252,850
|
|||||||||||
|
Selling and marketing expenses
|
67,980
|
46,827
|
132,350
|
93,058
|
|||||||||||
|
General, administrative and other expenses
|
30,208
|
27,364
|
60,868
|
53,652
|
|||||||||||
|
Operating income
|
82,830
|
53,850
|
158,110
|
106,140
|
|||||||||||
|
Other expense, net:
|
|||||||||||||||
|
Interest expense, net
|
(2,646
|
)
|
(3,786
|
)
|
(5,185
|
)
|
(6,975
|
)
|
|||||||
|
Other expense, net
|
(118
|
)
|
(73
|
)
|
(721
|
)
|
(5
|
)
|
|||||||
|
Total other expense
|
(2,764
|
)
|
(3,859
|
)
|
(5,906
|
)
|
(6,980
|
)
|
|||||||
|
Income before income taxes
|
80,066
|
49,991
|
152,204
|
99,160
|
|||||||||||
|
Income tax provision
|
26,982
|
16,485
|
50,860
|
32,506
|
|||||||||||
|
Net income
|
$
|
53,084
|
$
|
33,506
|
$
|
101,344
|
$
|
66,654
|
|||||||
|
Earnings per common share:
|
|||||||||||||||
|
Basic
|
$
|
0.78
|
$
|
0.47
|
$
|
1.48
|
$
|
0.93
|
|||||||
|
Diluted
|
$
|
0.76
|
$
|
0.46
|
$
|
1.44
|
$
|
0.90
|
|||||||
|
Weighted average common shares outstanding:
|
|||||||||||||||
|
Basic
|
67,959
|
70,730
|
68,257
|
72,014
|
|||||||||||
|
Diluted
|
70,018
|
73,152
|
70,469
|
74,438
|
|||||||||||
|
June 30,
2011
|
December 31,
2010
|
|||||
|
(Unaudited)
|
||||||
|
ASSETS
|
||||||
|
Current Assets:
|
||||||
|
Cash and cash equivalents
|
$
|
86,739
|
$
|
53,623
|
||
|
Accounts receivable, net
|
140,413
|
115,630
|
||||
|
Inventories
|
86,279
|
69,856
|
||||
|
Prepaid expenses and other current assets
|
24,333
|
18,646
|
||||
|
Deferred income taxes
|
12,199
|
13,725
|
||||
|
Total Current Assets
|
349,963
|
271,480
|
||||
|
Property, plant and equipment, net
|
162,081
|
159,807
|
||||
|
Goodwill
|
213,602
|
212,468
|
||||
|
Other intangible assets, net
|
66,940
|
68,745
|
||||
|
Other non-current assets
|
9,439
|
3,503
|
||||
|
Total Assets
|
$
|
802,025
|
$
|
716,003
|
||
|
LIABILITIES AND STOCKHOLDERS’ EQUITY
|
||||||
|
Current Liabilities:
|
||||||
|
Accounts payable
|
$
|
63,246
|
$
|
48,288
|
||
|
Accrued expenses and other current liabilities
|
85,803
|
85,469
|
||||
|
Income taxes payable
|
18,714
|
12,477
|
||||
|
Total Current Liabilities
|
167,763
|
146,234
|
||||
|
Long-term debt
|
475,000
|
407,000
|
||||
|
Deferred income taxes
|
30,787
|
32,315
|
||||
|
Other non-current liabilities
|
4,512
|
4,421
|
||||
|
Total Liabilities
|
678,062
|
589,970
|
||||
|
Commitments and contingencies—see Note 9
|
||||||
|
Total Stockholders’ Equity
|
123,963
|
126,033
|
||||
|
Total Liabilities and Stockholders’ Equity
|
$
|
802,025
|
$
|
716,003
|
||
|
Six Months Ended
June 30,
|
||||||||
|
2011
|
2010
|
|||||||
|
CASH FLOWS FROM OPERATING ACTIVITIES:
|
||||||||
|
Net income
|
$
|
101,344
|
$
|
66,654
|
||||
|
Adjustments to reconcile net income to net cash provided by
operating activities:
|
||||||||
|
Depreciation and amortization
|
16,590
|
15,706
|
||||||
|
Amortization of stock-based compensation
|
7,719
|
5,339
|
||||||
|
Amortization of deferred financing costs
|
346
|
345
|
||||||
|
Bad debt expense
|
1,137
|
1,278
|
||||||
|
Deferred income taxes
|
(1,133
|
)
|
1,275
|
|||||
|
Foreign currency adjustments and other
|
826
|
(2,150
|
)
|
|||||
|
Changes in operating assets and liabilities
|
(22,879
|
)
|
(20,625
|
)
|
||||
|
Net cash provided by operating activities
|
103,950
|
67,822
|
||||||
|
CASH FLOWS FROM INVESTING ACTIVITIES:
|
||||||||
|
Acquisition of business, net of cash acquired
|
—
|
(18,692
|
)
|
|||||
|
Acquisition of trademarks and other
|
(1,970
|
)
|
(184
|
)
|
||||
|
Purchases of property, plant and equipment
|
(12,098
|
)
|
(6,698
|
)
|
||||
|
Net cash used by investing activities
|
(14,068
|
)
|
(25,574
|
)
|
||||
|
CASH FLOWS FROM FINANCING ACTIVITIES:
|
||||||||
|
Proceeds from long-term revolving credit facility
|
572,500
|
222,336
|
||||||
|
Repayments of long-term revolving credit facility
|
(504,500
|
)
|
(83,313
|
)
|
||||
|
Payments of deferred finance costs
|
(6,109
|
)
|
—
|
|||||
|
Proceeds from issuance of common stock
|
22,386
|
19,470
|
||||||
|
Excess tax benefit from stock based compensation
|
14,133
|
2,613
|
||||||
|
Treasury shares repurchased
|
(160,010
|
)
|
(200,000
|
)
|
||||
|
Net cash used by financing activities
|
(61,600
|
)
|
(38,894)
|
|||||
|
NET EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS
|
4,834
|
(2,029
|
)
|
|||||
|
Increase in cash and cash equivalents
|
33,116
|
1,325
|
||||||
|
CASH AND CASH EQUIVALENTS, beginning of period
|
53,623
|
14,042
|
||||||
|
CASH AND CASH EQUIVALENTS, end of period
|
$
|
86,739
|
$
|
15,367
|
||||
|
Supplemental cash flow information:
|
||||||||
|
Cash paid during the period for:
|
||||||||
|
Interest
|
$
|
4,973
|
$
|
6,397
|
||||
|
Income taxes, net of refunds
|
$
|
32,721
|
$
|
23,641
|
||||
|
June 30,
2011
|
December 31,
2010
|
||||||
|
Finished goods
|
$ | 66,674 | $ | 53,362 | |||
|
Work-in-process
|
7,325 | 5,549 | |||||
|
Raw materials and supplies
|
12,280 | 10,945 | |||||
| $ | 86,279 | $ | 69,856 | ||||
|
Balance as of December 31, 2010
|
$ | 4,402 | |
|
Amounts accrued
|
25,637 | ||
|
Returns charged to accrual
|
(24,000 | ) | |
|
Balance as of June 30, 2011
|
$ | 6,039 |
|
Balance as of December 31, 2010
|
$ | 4,081 | |
|
Amounts accrued
|
3,212 | ||
|
Warranties charged to accrual
|
(2,800 | ) | |
|
Balance as of June 30, 2011
|
$ | 4,493 |
|
North America
|
International
|
Total
|
|||||||||
|
Balance as of December 31, 2010
|
$ | 108,931 | $ | 103,537 | $ | 212,468 | |||||
|
Foreign currency translation adjustments
|
594 | 540 | 1,134 | ||||||||
|
Balance as of June 30, 2011
|
$ | 109,525 | $ | 104,077 | $ | 213,602 | |||||
|
June 30, 2011
|
December 31, 2010
|
|||||||||||||||||||||
|
Useful
|
Gross
|
Net
|
Gross
|
Net
|
||||||||||||||||||
|
Lives
|
Carrying
|
Accumulated
|
Carrying
|
Carrying
|
Accumulated
|
Carrying
|
||||||||||||||||
|
(Years)
|
Amount
|
Amortization
|
Amount
|
Amount
|
Amortization
|
Amount
|
||||||||||||||||
|
Unamortized indefinite
life intangible assets:
|
||||||||||||||||||||||
|
Trademarks
|
$ | 55,000 | $ | — | $ | 55,000 | $ | 55,000 | $ | — | $ | 55,000 | ||||||||||
|
Amortized intangible
assets:
|
||||||||||||||||||||||
|
Technology
|
10 | $ | 16,000 | $ | 13,867 | $ | 2,133 | $ | 16,000 | $ | 13,067 | $ | 2,933 | |||||||||
|
Patents & other
trademarks
|
5-20 | 12,609 | 8,896 | 3,713 | 12,063 | 8,575 | 3,488 | |||||||||||||||
|
Customer database
|
5 | 4,864 | 4,798 | 66 | 4,813 | 4,691 | 122 | |||||||||||||||
|
Foam formula
|
10 | 3,700 | 3,207 | 493 | 3,700 | 3,022 | 678 | |||||||||||||||
|
Reacquired rights
|
3 | 5,948 | 2,478 | 3,470 | 5,767 | 1,440 | 4,327 | |||||||||||||||
|
Customer relationships
|
5 | 2,599 | 534 | 2,065 | 2,492 | 295 | 2,197 | |||||||||||||||
|
Total
|
$ | 100,720 | $ | 33,780 | $ | 66,940 | $ | 99,835 | $ | 31,090 | $ | 68,745 | ||||||||||
| June 30, 2011 | December 31, 2010 | ||||||
| Senior Credit Facility: | |||||||
|
Domestic Long-Term Revolving Credit Facility payable to lenders, interest at
Base Rate or LIBOR plus applicable margin (1.94% and 1.87% as of
June 30, 2011 and December 31, 2010, respectively), commitment through and due June 28, 2016
|
$ | 475,000 | $ | 407,000 | |||
| Long Term Debt | $ | 475,000 | $ | 407,000 |
|
Fair Value Measurements at June 30, 2011 Using:
|
|||||||||||||||
|
June 30, 2011
|
Quoted Prices in Active
Markets for Identical
Assets (Level 1)
|
Significant Other
Observable Inputs (Level 2)
|
Significant
Unobservable Inputs
(Level 3)
|
||||||||||||
|
Liabilities:
|
|||||||||||||||
|
Foreign currency forward contracts
|
$ | 52 | $ | — | $ | 52 | $ | — | |||||||
|
Fair Value Measurements at December 31, 2010 Using:
|
|||||||||||||||
|
December 31, 2010
|
Quoted Prices in Active
Markets for Identical
Assets (Level 1)
|
Significant Other
Observable Inputs (Level 2)
|
Significant
Unobservable Inputs
(Level 3)
|
||||||||||||
|
Liabilities:
|
|||||||||||||||
|
Foreign currency forward contracts
|
$
|
676
|
$
|
—
|
$
|
676
|
$
|
—
|
|||||||
|
Interest rate swap
|
$
|
1,430
|
$
|
—
|
$
|
1,430
|
$
|
—
|
|||||||
|
Foreign Currency Denomination
|
Notional Amount
|
||||
|
Japanese Yen
|
¥ | 493,695 | |||
|
Swedish Krona
|
kr. | 8,755 | |||
|
Norwegian Krone
|
kr. | 8,389 | |||
|
Australian Dollar
|
$ | 2,834 | |||
|
New Zealand Dollar
|
$ | 1,518 | |||
|
Singapore Dollar
|
$ | 1,011 | |||
|
Canadian Dollar
|
$ | 826 | |||
|
United States Dollar
|
$ | 14,927 | |||
|
Liability Derivatives
|
|||||||||||||
|
June 30, 2011
|
December 31, 2010
|
||||||||||||
|
Balance Sheet Location
|
Fair Value
|
Balance Sheet Location
|
Fair Value
|
||||||||||
|
Derivatives designated as hedging instruments
|
|||||||||||||
|
Interest rate swap
|
Accrued expenses and other current liabilities
|
$
|
—
|
Accrued expenses and other current liabilities
|
$
|
1,430
|
|||||||
|
Derivatives not designated as hedging instruments
|
|||||||||||||
|
Foreign exchange forward contracts
|
Accrued expenses and other current liabilities
|
$
|
52
|
Accrued expenses and other current liabilities
|
$
|
676
|
|||||||
|
$
|
52
|
$
|
2,106
|
||||||||||
|
Derivatives Designated as Cash Flow Hedging Relationships
|
Amount of Gain/(Loss)
Recognized in Accumulated OCI on
Derivative
(Effective Portion)
|
Location of Gain/(Loss)
Reclassified from
Accumulated OCI into
Income
(Effective Portion)
|
Amount of Gain/(Loss)
Reclassified from
Accumulated OCI
into Income
(Effective Portion)
|
Location of Gain/(Loss)
Recognized in Income on
Derivative (Ineffective
Portion and Amount
Excluded from
Effectiveness Testing)
|
Amount of Gain/(Loss)
Recognized in Income
on Derivative
(Ineffective Portion
and Amount Excluded
from Effectiveness Testing)
|
||||||||||||||
|
Interest rate swap
|
$
|
582
|
Interest expense, net
|
$
|
(582
|
) |
|
Interest expense, net
|
$
|
—
|
|||||||||
|
Derivatives Not Designated as Hedging Instruments
|
Location of Gain/(Loss)
Recognized in Income on
Derivative
|
Amount of Gain/(Loss)
Recognized in Income
on Derivative
|
||||||
|
Foreign exchange forward contracts
|
Other expense, net
|
$
|
(211
|
)
|
||||
|
Derivatives Designated as Cash Flow Hedging Relationships
|
Amount of Gain/(Loss)
Recognized in Accumulated OCL on
Derivative
(Effective Portion)
|
Location of Gain/(Loss)
Reclassified from
Accumulated OCL into
Income
(Effective Portion)
|
Amount of Gain/(Loss)
Reclassified from
Accumulated OCL
into Income
(Effective Portion)
|
Location of Gain/(Loss)
Recognized in Income on
Derivative (Ineffective
Portion and Amount
Excluded from
Effectiveness Testing)
|
Amount of Gain/(Loss)
Recognized in Income
on Derivative
(Ineffective Portion
and Amount Excluded
from Effectiveness Testing)
|
||||||||||||||
|
Interest rate swap
|
$
|
1,788
|
Interest expense, net
|
$
|
(1,757
|
) |
|
Interest expense, net
|
$
|
—
|
|||||||||
|
Derivatives Not Designated as Hedging Instruments
|
Location of Gain/(Loss)
Recognized in Income on
Derivative
|
Amount of Gain/(Loss)
Recognized in Income
on Derivative
|
||||||
|
Foreign exchange forward contracts
|
Other expense, net
|
$
|
(387
|
)
|
||||
|
Derivatives Designated as Cash Flow Hedging Relationships
|
Amount of Gain/(Loss)
Recognized in Accumulated OCL on
Derivative
(Effective Portion)
|
Location of Gain/(Loss)
Reclassified from
Accumulated OCL into
Income
(Effective Portion)
|
Amount of Gain/(Loss)
Reclassified from
Accumulated OCL
into Income
(Effective Portion)
|
Location of Loss
Recognized in Income on
Derivative (Ineffective
Portion and Amount
Excluded from
Effectiveness Testing)
|
Amount of Loss
Recognized in Income
on Derivative
(Ineffective Portion
and Amount Excluded
from Effectiveness Testing)
|
||||||||||||||
|
Interest rate swap
|
$
|
1,430
|
Interest expense, net
|
$
|
(1,446
|
) |
Interest expense, net
|
$
|
—
|
||||||||||
|
Derivatives Not Designated as Hedging Instruments
|
Location of Gain/(Loss)
Recognized in Income on
Derivative
|
Amount of Gain/(Loss)
Recognized in Income
on Derivative
|
||||||
|
Foreign exchange forward contracts
|
Other expense, net
|
$
|
1,038
|
|||||
|
Derivatives Designated as Cash Flow Hedging Relationships
|
Amount of
Gain/(Loss)
Recognized in Accumulated OCL on
Derivative
(Effective Portion)
|
Location of Gain/(Loss)
Reclassified from
Accumulated OCL into
Income
(Effective Portion)
|
Amount of Gain/(Loss)
Reclassified from
Accumulated OCL
into Income
(Effective Portion)
|
Location of Gain/(Loss)
Recognized in Income on
Derivative (Ineffective
Portion and Amount
Excluded from
Effectiveness Testing)
|
Amount of Gain/(Loss)
Recognized in Income
on Derivative
(Ineffective Portion
and Amount Excluded
from Effectiveness Testing)
|
||||||||||||||
|
Interest rate swap
|
$
|
2,723
|
Interest expense, net
|
$
|
(3,488
|
) |
Interest expense, net
|
$
|
—
|
||||||||||
|
Derivatives Not Designated as Hedging Instruments
|
Location of Gain/(Loss)
Recognized in Income on
Derivative
|
Amount of Gain/(Loss)
Recognized in Income
on Derivative
|
||||||
|
Foreign exchange forward contracts
|
Other expense, net
|
(1,353
|
) | |||||
|
June 30, 2011
|
December 31, 2010
|
||||||
|
Land and buildings
|
$
|
126,331
|
$
|
121,188
|
|||
|
Machinery and equipment, furniture and fixtures and other
|
221,150
|
208,310
|
|||||
|
Construction in progress
|
12,449
|
9,858
|
|||||
|
359,930
|
339,356
|
||||||
|
Accumulated depreciation
|
(197,849
|
) |
(179,549
|
) | |||
|
$
|
162,081
|
$
|
159,807
|
||||
|
June 30, 2011
|
December 31, 2010
|
||||||
|
Salary and related expenses
|
$
|
18,509
|
$
|
22,171
|
|||
|
Accrued unrecognized tax benefits
|
12,153
|
12,035
|
|||||
|
Advertising accrual
|
|
12,215
|
6,981
|
||||
|
Accrued sales and value added taxes
|
8,614
|
10,614
|
|||||
|
Sales returns
|
4,493
|
4,081
|
|||||
|
Warranty accrual
|
6,039
|
4,402
|
|||||
|
Other
|
23,780
|
25,185
|
|||||
|
$
|
85,803
|
$
|
85,469
|
|
June 30, 2011
|
December 31, 2010
|
||||||
|
Derivative instruments accounted for as hedges, net of taxes of $0 and $558
|
$ | — | $ | (872 | ) | ||
|
Foreign currency translation adjustments
|
6,170 | (5,316 | ) | ||||
|
Accumulated other comprehensive income (loss)
|
$ | 6,170 | $ | (6,188 | ) | ||
|
Three Months Ended
|
Six Months Ended
|
|||||||||||||||
|
June 30,
|
June 30,
|
|||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||
|
Net income
|
$ | 53,084 | $ | 33,506 | $ | 101,344 | $ | 66,654 | ||||||||
|
Derivative instruments accounted for as hedges, net of taxes of $227, $698, $558 and $1,063, respectively
|
355 | 1,091 | 872 | 1,661 | ||||||||||||
|
Cumulative translation adjustment
|
3,996 | (7,892 | ) | 11,486 | (13,320 | ) | ||||||||||
|
Total comprehensive income
|
$ | 57,435 | $ | 26,705 | $ | 113,702 | $ | 54,995 | ||||||||
|
Expected volatility of stock
|
72.25 | % | ||
|
Expected life of options, in years
|
3.0 | |||
|
Risk-free interest rate
|
1.09 | % | ||
|
Expected dividend yield on stock
|
0.0 | % |
|
Three Months Ended
|
Six Months Ended
|
||||||||||||||
|
June 30,
|
June 30,
|
||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
||||||||||||
|
Numerato
r:
|
|||||||||||||||
|
Net income
|
$ | 53,084 | $ | 33,506 | $ | 101,344 | $ | 66,654 | |||||||
|
Denominator:
|
|||||||||||||||
|
Denominator for basic earnings per common share-weighted average shares
|
67,959 | 70,730 | 68,257 | 72,014 | |||||||||||
|
Effect of dilutive securities:
|
|||||||||||||||
|
Employee stock options
|
2,059 | 2,422 | 2,212 | 2,424 | |||||||||||
|
Denominator for diluted earnings per common share-adjusted weighted average shares
|
70,018 | 73,152 | 70,469 | 74,438 | |||||||||||
|
Basic earnings per common share
|
$ | 0.78 | $ | 0.47 | $ | 1.48 | $ | 0.93 | |||||||
|
Diluted earnings per common share
|
$ | 0.76 | $ | 0.46 | $ | 1.44 | $ | 0.90 | |||||||
|
June 30, 2011
|
December 31, 2010
|
||||||
|
Total assets:
|
|||||||
|
North America
|
$ | 646,311 | $ | 576,139 | |||
|
International
|
388,075 | 338,685 | |||||
|
Intercompany eliminations
|
(232,361 | ) | (198,821 | ) | |||
| $ | 802,025 | $ | 716,003 | ||||
|
Three Months Ended
|
Six Months Ended
|
||||||||||||||
|
June 30,
|
June 30,
|
||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
||||||||||||
|
Net sales from external customers:
|
|||||||||||||||
|
North America
|
|||||||||||||||
|
Mattresses
|
$ | 175,270 | $ | 136,686 | $ | 334,715 | $ | 254,072 | |||||||
|
Pillows
|
16,731 | 14,058 | 34,320 | 28,187 | |||||||||||
|
Other
|
55,111 | 41,478 | 107,080 | 76,516 | |||||||||||
| $ | 247,112 | $ | 192,222 | $ | 476,115 | $ | 358,775 | ||||||||
|
International
|
|||||||||||||||
|
Mattresses
|
$ | 57,348 | $ | 41,932 | $ | 115,239 | $ | 93,617 | |||||||
|
Pillows
|
18,155 | 13,867 | 35,278 | 30,484 | |||||||||||
|
Other
|
19,597 | 15,023 | 41,418 | 34,057 | |||||||||||
| $ | 95,100 | $ | 70,822 | $ | 191,935 | $ | 158,158 | ||||||||
| $ | 342,212 | $ | 263,044 | $ | 668,050 | $ | 516,933 | ||||||||
|
Inter-segment sales:
|
|||||||||||||||
|
North America
|
38 | — | 314 | — | |||||||||||
|
International
|
$ | 503 | $ | 456 | $ | 1,227 | $ | 661 | |||||||
|
Intercompany eliminations
|
(541 | ) | (456 | ) | (1,541 | ) | (661 | ) | |||||||
| $ | — | $ | — | $ | — | $ | — | ||||||||
|
Gross Profit
|
|||||||||||||||
|
Domestic
|
$ | 124,211 | $ | 87,957 | $ | 236,016 | $ | 161,917 | |||||||
|
International
|
56,807 | 40,084 | 115,312 | 90,933 | |||||||||||
| $ | 181,018 | $ | 128,041 | $ | 351,328 | $ | 252,850 | ||||||||
|
Operating income:
|
|||||||||||||||
|
North America
|
$ | 59,317 | $ | 36,076 | $ | 110,399 | $ | 63,123 | |||||||
|
International
|
23,513 | 17,774 | 47,711 | 43,017 | |||||||||||
| $ | 82,830 | $ | 53,850 | $ | 158,110 | $ | 106,140 | ||||||||
|
Depreciation and amortization
(including stock-based
compensation amortization):
|
|||||||||||||||
|
North America
|
$ | 10,614 | $ | 8,873 | $ | 19,260 | $ | 16,603 | |||||||
|
International
|
2,625 | 2,176 | 5,049 | 4,442 | |||||||||||
| $ | 13,239 | $ | 11,049 | $ | 24,309 | $ | 21,045 | ||||||||
|
Capital expenditures:
|
|||||||||||||||
|
North America
|
$ | 3,977 | $ | 2,578 | $ | 6,958 | $ | 3,927 | |||||||
|
International
|
2,906 | 1,449 | 5,140 | 2,771 | |||||||||||
|
|
$ | 6,883 | $ | 4,027 | $ | 12,098 | $ | 6,698 | |||||||
|
MANAGEMENT’S DISCUSSION AND
ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS
|
|
·
|
Our Net sales and costs in the periods presented as well as changes between periods;
|
|
·
|
Discussion of new initiatives that may affect our future results of operations and financial condition;
|
|
·
|
Expected future expenditures for capital projects and sources of liquidity for future operations; and
|
|
·
|
The effect of the foregoing on our overall financial performance and condition, as well as factors that could affect our future performance.
|
|
·
|
Make sure everyone knows that they would sleep better on a Tempur-Pedic - we plan to continue to invest in our global brand awareness through advertising campaigns that further associate our brand name with overall sleep and premium quality products.
|
|
·
|
Make sure there is a Tempur-Pedic bed and pillow that appeals to everyone - we plan to continue to maintain our focus on premium mattresses and pillows and regularly introducing new products.
|
|
·
|
Make sure that Tempur-Pedic is available to everyone - we plan to expand our points of distribution and the effectiveness of our distribution channels.
|
|
·
|
Make sure that Tempur-Pedic continues to deliver the best sleep - we plan to continue to invest in product research and development.
|
|
·
|
Earnings per diluted common share (EPS) were $0.76 for the three months ended June 30, 2011 compared to $0.46 for the three months ended June 30, 2010. For the six months ended June 30, 2011 EPS were $1.44 compared to $0.90 for the same period in 2010.
|
|
·
|
Net sales for the three months ended June 30, 2011 increased to $342.2 million from $263.0 million for the same period in 2010. Net sales for the six months ended June 30, 2011 increased to $668.1 million from $516.9 million for the same period in 2010.
|
|
·
|
Our Gross profit margin in the second quarter of 2011 was 52.9% compared to 48.7% for the second quarter of 2010. For the six months ended June 30, 2011 our Gross profit margin was 52.6% compared to 48.9% for the same period in 2010.
|
|
·
|
During the six months ended June 30, 2011 we generated $104.0 million of operating cash flow compared to $67.8 million for the six months ended June 30, 2010.
|
|
(In thousands, except per common share amounts)
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
|||||||||||||||||||||
|
2011
|
2010
|
2011
|
2010
|
||||||||||||||||||||
|
Net sales
|
$ | 342,212 | 100.0 | % | $ | 263,044 | 100.0 | % | $ | 668,050 | 100.0 | % | $ | 516,933 | 100.0 | % | |||||||
|
Cost of sales
|
161,194 | 47.1 | 135,003 | 51.3 | 316,722 | 47.4 | 264,083 | 51.1 | |||||||||||||||
|
Gross profit
|
181,018 | 52.9 | 128,041 | 48.7 | 351,328 | 52.6 | 252,850 | 48.9 | |||||||||||||||
|
Selling and marketing expenses
|
67,980 | 19.9 | 46,827 | 17.8 | 132,350 | 19.8 | 93,058 | 18.0 | |||||||||||||||
|
General, administrative and other expenses
|
30,208 | 8.8 | 27,364 | 10.4 | 60,868 | 9.1 | 53,652 | 10.4 | |||||||||||||||
|
Operating income
|
82,830 | 24.2 | 53,850 | 20.5 | 158,110 | 23.7 | 106,140 | 20.5 | |||||||||||||||
|
Interest expense, net
|
(2,646 | ) | (0.8 | ) | (3,786 | ) | (1.5 | ) | (5,185 | ) | (0.8 | ) | (6,975 | ) | (1.3 | ) | |||||||
|
Other expense, net
|
(118 | ) | — | (73 | ) | — | (721 | ) | (0.1 | ) | (5 | ) | — | ||||||||||
|
Income before income taxes
|
80,066 | 23.4 | 49,991 | 19.0 | 152,204 | 22.8 | 99,160 | 19.2 | |||||||||||||||
|
Income tax provision
|
26,982 | 7.9 | 16,485 | 6.3 | 50,860 | 7.6 | 32,506 | 6.3 | |||||||||||||||
|
Net income
|
$ | 53,084 | 15.5 | % | $ | 33,506 | 12.7 | % | $ | 101,344 | 15.2 | % | $ | 66,654 | 12.9 | % | |||||||
|
Earnings per common share:
|
|||||||||||||||||||||||
|
Basic
|
$ | 0.78 | $ | 0.47 | $ | 1.48 | $ | 0.93 | |||||||||||||||
|
Diluted
|
$ | 0.76 | $ | 0.46 | $ | 1.44 | $ | 0.90 | |||||||||||||||
|
Weighted average common shares outstanding:
|
|||||||||||||||||||||||
|
Basic
|
67,959 | 70,730 | 68,257 | 72,014 | |||||||||||||||||||
|
Diluted
|
70,018 | 73,152 | 70,469 | 74,438 | |||||||||||||||||||
|
CONSOLIDATED
|
NORTH AMERICA
|
INTERNATIONAL
|
|||||||||||||||||||||
|
Three Months Ended
|
Three Months Ended
|
Three Months Ended
|
|||||||||||||||||||||
|
June 30,
|
June 30,
|
June 30,
|
|||||||||||||||||||||
|
(in thousands)
|
2011
|
2010
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||||||
|
Retail
|
$ | 299,024 | $ | 226,376 | $ | 227,186 | $ | 173,166 | $ | 71,838 | $ | 53,210 | |||||||||||
|
Direct
|
22,884 | 18,902 | 17,296 | 16,203 | 5,588 | 2,699 | |||||||||||||||||
|
Healthcare
|
8,000 | 7,898 | 2,630 | 2,853 | 5,370 | 5,045 | |||||||||||||||||
|
Third Party
|
12,304 | 9,868 | — | — | 12,304 | 9,868 | |||||||||||||||||
| $ | 342,212 | $ | 263,044 | $ | 247,112 | $ | 192,222 | $ | 95,100 | $ | 70,822 | ||||||||||||
|
CONSOLIDATED
|
NORTH AMERICA
|
INTERNATIONAL
|
|||||||||||||||||||||
|
Three Months Ended
|
Three Months Ended
|
Three Months Ended
|
|||||||||||||||||||||
|
June 30,
|
June 30,
|
June 30,
|
|||||||||||||||||||||
|
(in thousands)
|
2011
|
2010
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||||||
|
Mattresses
|
$ | 232,618 | $ | 178,618 | $ | 175,270 | $ | 136,686 | $ | 57,348 | $ | 41,932 | |||||||||||
|
Pillows
|
34,886 | 27,925 | 16,731 | 14,058 | 18,155 | 13,867 | |||||||||||||||||
|
Other
|
74,708 | 56,501 | 55,111 | 41,478 | 19,597 | 15,023 | |||||||||||||||||
| $ | 342,212 | $ | 263,044 | $ | 247,112 | $ | 192,222 | $ | 95,100 | $ | 70,822 | ||||||||||||
|
CONSOLIDATED
|
NORTH AMERICA
|
INTERNATIONAL
|
|||||||||||||||||||||
|
Six Months Ended
|
Six Months Ended
|
Six Months Ended
|
|||||||||||||||||||||
|
June 30,
|
June 30,
|
June 30,
|
|||||||||||||||||||||
|
(In thousands)
|
2011
|
2010
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||||||
|
Retail
|
$ | 583,454 | $ | 438,275 | $ | 435,334 | $ | 316,383 | $ | 148,120 | $ | 121,892 | |||||||||||
|
Direct
|
46,074 | 36,357 | 35,256 | 30,758 | 10,818 | 5,599 | |||||||||||||||||
|
Healthcare
|
16,997 | 17,796 | 5,525 | 6,291 | 11,472 | 11,505 | |||||||||||||||||
|
Third Party
|
21,525 | 24,505 | — | 5,343 | 21,525 | 19,162 | |||||||||||||||||
| $ | 668,050 | $ | 516,933 | $ | 476,115 | $ | 358,775 | $ | 191,935 | $ | 158,158 | ||||||||||||
|
CONSOLIDATED
|
NORTH AMERICA
|
INTERNATIONAL
|
|||||||||||||||||||||
|
Six Months Ended
|
Six Months Ended
|
Six Months Ended
|
|||||||||||||||||||||
|
June 30,
|
June 30,
|
June 30,
|
|||||||||||||||||||||
|
(In thousands)
|
2011
|
2010
|
2011
|
2010
|
2011
|
2010
|
|||||||||||||||||
|
Mattresses
|
$ | 449,954 | $ | 347,689 | $ | 334,715 | $ | 254,072 | $ | 115,239 | $ | 93,617 | |||||||||||
|
Pillows
|
69,598 | 58,671 | 34,320 | 28,187 | 35,278 | 30,484 | |||||||||||||||||
|
Other
|
148,498 | 110,573 | 107,080 | 76,516 | 41,418 | 34,057 | |||||||||||||||||
| $ | 668,050 | $ | 516,933 | $ | 476,115 | $ | 358,775 | $ | 191,935 | $ | 158,158 | ||||||||||||
|
Three Months Ended
|
Twelve Months Ended
|
||||||||||||||||||
|
(In thousands)
|
September 30, 2010
|
December 31, 2010
|
March 31, 2011
|
June 30, 2011
|
June 30, 2011
|
||||||||||||||
|
GAAP Net income
|
$ | 44,198 | $ | 46,292 | $ | 48,260 | $ | 53,084 | $ | 191,834 | |||||||||
|
Plus:
|
|||||||||||||||||||
|
Interest expense
|
4,068 | 3,458 | 2,539 | 2,646 | 12,711 | ||||||||||||||
|
Income taxes
|
19,324 | 21,890 | 23,878 | 26,982 | 92,074 | ||||||||||||||
|
Depreciation &
Amortization
|
10,778 | 12,146 | 11,070 | 13,239 | 47,233 | ||||||||||||||
|
EBITDA
|
$ | 78,368 | $ | 83,786 | $ | 85,747 | $ | 95,951 | $ | 343,852 | |||||||||
|
As of
|
||||
|
(In thousands)
|
June 30, 2011
|
|||
|
GAAP basis Total debt
|
$ | 475,000 | ||
|
Plus:
|
||||
|
Letters of credit outstanding
|
990 | |||
|
Funded debt
|
$ | 475,990 | ||
|
EBITDA
|
$ | 343,852 | ||
|
Funded debt to EBITDA
|
1.38 times | |||
|
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
|
|
CONTROLS AND PROCEDURES
|
|
|
OTHER INFORMATION
|
|
LEGAL PROCEEDINGS
|
|
RISK FACTORS
|
|
UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS
|
|
Period
|
(a) Total
number
of shares
purchased
|
(b) Average Price
Paid per Share
|
(c) Total number of
shares purchased as
part of publicly
announced plans or
programs
|
(d) Maximum number of
shares
(or approximate dollar value)
of shares that may yet be
purchased under the plans or
programs (in millions)
|
|||||||||||||
|
April 1, 2011 – April 30, 2011
|
— | — | — | — | |||||||||||||
|
May 1, 2011 – May 31, 2011
|
688,834 | $ | 62.69 | 688,834 | $ | 94.3 | |||||||||||
|
June 1, 2011 – June 30, 2011
|
904,367 | $ | 60.05 | 904,367 | $ | 40.0 | |||||||||||
|
Total
|
1,593,201 | 1,593,201 | |||||||||||||||
|
DEFAULTS
UPON SENIOR SECURITIES
|
|
OTHER INFORMATION
|
|
EXHIBITS
|
| 10.1 | Amended and Restated Credit Agreement, dated as of June 28, 2011 among Tempur-Pedic Management, Inc., Dan-Foam ApS, and certain Subsidiaries and Affiliates, as Borrowers; Tempur-Pedic International Inc., Tempur World, LLC, and Certain Subsidiaries and Affiliates of the Borrowers as Guarantors; Bank of America, N.A., as Domestic Administrative Agent and Domestic Collateral Agent; Nordea Bank Danmark A/S, as Foreign Administrative Agent, European Co-Agent and Foreign Collateral Agent; Fifth Third Bank and JPMorgan Chase Bank, N.A. as U.S. Co-Agents; Wells Fargo Bank National Association, as Syndication Agent; Merrill Lynch, Piece, Fenner & Smith Incorporated and Wells Fargo Securities, LLC, as Joint Lead Arrangers and Joint Book Managers (filed as Exhibit 10.1 to Registrant’s Current Report on Form 8-K as filed on June 29, 2011). (1) | ||
| 31.1 | Certification of Chief Executive Officer, pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
| 31.2 | Certification of Chief Financial Officer, pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. | ||
| 32.1 | Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | ||
| 101 |
The following materials from Tempur-Pedic International Inc.'s Quarterly Report on Form 10-Q for the quarter ended June 30, 2011, formatted in XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Statements of Income, (ii) the Condensed Consolidated Balance Sheets, (iii) the Condensed Consolidated Statements of Cash Flows, and (iv) the Notes to the Condensed Consolidated Financial Statements, tagged as blocks of text.
|
||
| (1) |
Incorporated by reference.
|
||
| * | This exhibit shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (15 U.S.C. 78r), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filings under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date hereof and irrespective of any general incorporation language in any filings. |
| TEMPUR-PEDIC INTERNATIONAL INC. | |||
|
July 27, 2011
|
By:
|
/s/ DALE E. WILLIAMS | |
| Dale E. Williams | |||
| Executive Vice President and Chief Financial Officer | |||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|